Maria Hopman is creating an e-health program for cardiac rehabilitation together with a consortium of Danish and Swiss companies. The consortium has been awarded a Eurostars grant of € 1.9 million for this program. Starting in 2021, the program will be available for physiotherapists and hospitals in Europe.Every year, more than 3 million people in Europe experience a heart attack. For half of them, this is not the first time. Most of these recurrent heart attacks can be prevented by improving the lifestyle after the first heart attack, for which patients are often offered cardiac rehabilitation. These programs consist of exercise and lifestyle recommendations. Cardiac rehabilitation is provided at specialized centers.
According to estimates, if all cardiac patients were to undergo cardiac rehabilitation, the mortality from myocardial infarctions could fall by 26 percent and hospital admissions by more than 30 percent. Despite these benefits, less than half of cardiac patients receive cardiac rehabilitation. This lack of participation is mainly due the distance to the cardiac rehabilitation centers, which patients experience as being too far. There are also many objections to the limited possibilities for taking an individualized program.
Research has shown that an internet-based rehabilitation program can achieve the same results as rehabilitation at a center. An e-health application for cardiac rehabilitation could therefore eliminate many obstacles for patients. However, such an application is not yet available. With Eurostar funding of € 1.9 million, a European consortium of researchers and companies will create CaRe, a mobile platform for cardiac rehabilitation.
CaRe is a consortium consisting of the Danish companies Welfare Denmark and Tutee, the Swiss company Ateleris and the research group of Maria Hopman at Radboud university medical center. With the CaRe program, patients can rehabilitate at home. They can set their own goals, maintain contact with their therapist via the internet and follow an individualized training program. The initiators of CaRe hope that this will increase the number of participants in cardiac rehabilitation.
CaRe is expected to be available worldwide in 2021 to physiotherapists and hospitals offering cardiac rehabilitation.
Eurostars is an EU program of the Eureka network for financing projects led by small or medium-sized companies that spend at least 10% of their turnover or working hours on research activities.
Maria Hopman is member of theme Mitochondrial diseases.
Related news items
4,8 million euros for prevention of tuberculosis among people with diabetes in Africa16 July 2019
Reinout van Crevel and Lindsey te Brake have received European funding of 4.8 million euros to lead an international consortium to screen thousands of people with diabetes in Uganda and Tanzania for TB, and investigate the effect and costs of 3 months preventive treatment for TB.read more
Handbook of biomarkers and precision medicine a new publication by Alain van Gool12 July 2019
Alain van Gool published a new handbook on biomarkers and applications in (pre)clinical drug development for precision medicine.read more
The real impact of menstrual complaints on work and school productivity8 July 2019
Menstrual period symptoms may be linked to nearly nine days of lost productivity every year, through presenteeism, suggests the largest study of its kind, published in the journal BMJ Open. But the real impact on women and society is underestimated and poorly appreciated, say the researchers.read more
Walking for science Research by Radboud university medical center and Radboud University during the Vierdaagse (Four Day Marches)5 July 2019
The Vierdaagse is a unique opportunity to conduct research into physical activity and healthy lifestyle.read more
Prostate cancer theranostics imaging, surgical guidance, and targeted photodynamic therapy5 July 2019
In Theranostics, Mark Rijpkema and colleagues present the development of a novel multimodal tracer that targets both preoperative imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing prostate cancer.read more